Jianfei Fu

10PUBLICATIONS
3CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Cancer cell biologyOncology and carcinogenesis not elsewhere classifiedPharmacogenomics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (10)

|May 15, 2026
Topography-dependent Prognostic Value of CDK5 in Cetuximab-Treated, RAS/BRAF-wild-type Metastatic Colorectal Cancer: A Retrospective Tissue-Microarray Analysis.

|May 30, 2024
NRS2002 score as a prognostic factor in solid tumors treated with immune checkpoint inhibitor therapy: a real-world evidence analysis.

Wanfen Tang, Chenghui Li, Dong Huang

|Apr 11, 2023
Higher Levels of Tumour-Infiltrating Lymphocytes (TILs) are Associated with a Better Prognosis, While CDK5 Plays a Different Role Between Nonmetastatic and Metastatic Colonic Carcinoma.

Qinghua Wang, Ruihua Yin, Xiaoxiao Chen

|Apr 10, 2023
The value of PET/CT for the diagnosis and evaluation of immunotherapy in occult primary renal cell carcinoma: a case report.

Ting Jiang, Hongjuan Zheng, Ke Dong

|Jan 18, 2023
The impact of age on outcomes of breast cancer in different hormone receptor and HER2 groups.

Hongjuan Zheng, Chenyang Ge, Haiping Lin

|Nov 08, 2022
A Prediction Model for Chemotherapy-Induced Thrombocytopenia Based on Real-World Data and a Close Relationship Between AST/ALT Ratio and Platelet Count in Patients with Solid Tumors.

Bingxin Song, Shishi Zhou, Chenghui Li

Pageof 2

Frequent Collaborators

1 joint publications

Liang Fu

1 joint publications

Xianghong Ye

1 joint publications

Qinghua Wang